Respiratory Diagnostics Market

Respiratory Diagnostics - Global Market Outlook (2020 -2028)

4.8 (56 reviews)
Published: April 2021 ID: SMRC20422
4.8 (56 reviews)
Published: April 2021 ID: SMRC20422

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Respiratory Diagnostics Market is accounted for $6.94 billion in 2020 and is expected to reach $14.14 billion by 2028 growing at a CAGR of 9.3% during the forecast period. The rising prevalence of respiratory diseases and technological advancements are the major factors propelling market growth. However, reimbursement concerns are hampering market growth.

Respiratory diagnostics have a principal part in the therapeutic innovation area. It involves the clinical assessment of some kinds of respiratory conditions such as bronchitis, asthma, COPD, pulmonary fibrosis among others by using various kinds of mechanical, imaging, and molecular diagnostics tests.

Based on the test type, the traditional diagnostic tests segment is estimated to have a lucrative growth due to it is widely used by developing countries and the fast working time of these tests allows patients to get effective results in a shorter period which further improves treatment procedures.

By geography, North America is going to have a lucrative growth during the forecast period due to the increasing prevalence of respiratory diseases and the growing anti-aging population. The U.S. dominates North America's respiratory diagnostics market due to its advanced healthcare system and strong distribution channels.

Some of the key players profiled in the Respiratory Diagnostics Market include Abbott Diagnostics Inc., Becton, Dickinson and Company, CAREstream Medical Ltd., Fisher & Paykel Healthcare, Inc., GE Healthcare Limited, Koninklijke Philips N.V, Medtronic, Inc., MGC Diagnostics Corporation, ResMed Inc., Thermo Fisher Scientific Inc., 3M, Philips Healthcare, Biomérieux, COSMED, Bio-Rad Laboratories Inc., SDI Diagnostics, Seegene Inc., and Alere Inc.
Test Types Covered:
• Imaging Tests
• Mechanical Tests
• Molecular Diagnostic Tests
• Traditional Diagnostic Tests

Product and Services Covered:
• Assays and Kits/Reagents
• Instruments and Devices
• Services and Software

Diseases Covered:
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Tuberculosis
• Other Diseases

Distribution Channels Covered:
• Retail Sales
• Direct Tender

End Users Covered:
• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.